Affordable Access

Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease.

Authors
  • Magno, Priscilla
  • Jiménez, Carlos E
  • Ortiz, Zhamarie
  • Torres, Esther A
Type
Published Article
Journal
Puerto Rico health sciences journal
Publication Date
Mar 01, 2010
Volume
29
Issue
1
Pages
60–65
Identifiers
PMID: 20222336
Source
Medline
License
Unknown

Abstract

The small number of patients and the severity of their disease do not allow any conclusions about the drug effectiveness. Placebo-controlled studies, perhaps with less complicated patients, are needed to define a role, if any, of this therapy in fistulizing Crohn's disease.

Report this publication

Statistics

Seen <100 times